GPCR News

GPCR News http://gpcrcentral.wordpress.com GPCR News for the Pharma Industry Sat, 01 Nov 2008 16:48:50 +0000 en hourly 1 http://wordpress.com/ http://s2.wp.com/i/buttonw-com.png GPCR News http://gpcrcentral.wordpress.com Galenea license Organix 5-HT2C agonists http://gpcrcentral.wordpress.com/2008/11/01/galenea-license-organix-5-ht2c-agonists/ http://gpcrcentral.wordpress.com/2008/11/01/galenea-license-organix-5-ht2c-agonists/#comments Sat, 01 Nov 2008 16:48:50 +0000 crimsoncanary http://gpcrcentral.wordpress.com/?p=435 ]]> Galenea have licensed Organix’s 5-HT2C agonists for the treatment of obesity and other related disorders.

]]> http://gpcrcentral.wordpress.com/2008/11/01/galenea-license-organix-5-ht2c-agonists/feed/ 0 crimsoncanary Green Cross pubish series of CB1 antagonists http://gpcrcentral.wordpress.com/2008/11/01/green-cross-pubish-series-of-cb1-antagonists/ http://gpcrcentral.wordpress.com/2008/11/01/green-cross-pubish-series-of-cb1-antagonists/#comments Sat, 01 Nov 2008 16:35:56 +0000 crimsoncanary http://gpcrcentral.wordpress.com/?p=433 ]]> Green Cross have published a series of biarylpyrazolyl oxadiazole based compounds as CB1 antagonists

]]> http://gpcrcentral.wordpress.com/2008/11/01/green-cross-pubish-series-of-cb1-antagonists/feed/ 0 crimsoncanary Jenrin’s CB1 antagonists show efficacy with less adverse effects http://gpcrcentral.wordpress.com/2008/11/01/jenrins-cb1-antagonists-show-efficacy-with-less-adverse-effects/ http://gpcrcentral.wordpress.com/2008/11/01/jenrins-cb1-antagonists-show-efficacy-with-less-adverse-effects/#comments Sat, 01 Nov 2008 16:32:14 +0000 crimsoncanary http://gpcrcentral.wordpress.com/?p=431 ]]> Data presented at the Annual Scientific Meeting of the Obesity Society show Jenrin’s CB1 antagonist are capable of having a metabolic effect while reducing risks of psychiatric side effects.

]]> http://gpcrcentral.wordpress.com/2008/11/01/jenrins-cb1-antagonists-show-efficacy-with-less-adverse-effects/feed/ 0 crimsoncanary Resolor (Prucalopride) safe and effective in Severe Chronic Constipation http://gpcrcentral.wordpress.com/2008/10/24/resolor-prucalopride-safe-and-effective-in-severe-chronic-constipation/ http://gpcrcentral.wordpress.com/2008/10/24/resolor-prucalopride-safe-and-effective-in-severe-chronic-constipation/#comments Fri, 24 Oct 2008 17:12:22 +0000 crimsoncanary http://gpcrcentral.wordpress.com/?p=429 ]]> Data presented at the United European Gastroenterology Week show Movetis’ Prucalopride to demonstrate efficacy and safety in patients with chronic constipation.

]]> http://gpcrcentral.wordpress.com/2008/10/24/resolor-prucalopride-safe-and-effective-in-severe-chronic-constipation/feed/ 0 crimsoncanary Pfizer publish series of Alpha1A Adrenoceptor Partial Agonists http://gpcrcentral.wordpress.com/2008/10/24/pfizer-publish-series-of-alpha1a-adrenoceptor-partial-agonists/ http://gpcrcentral.wordpress.com/2008/10/24/pfizer-publish-series-of-alpha1a-adrenoceptor-partial-agonists/#comments Fri, 24 Oct 2008 16:57:14 +0000 crimsoncanary http://gpcrcentral.wordpress.com/?p=427 ]]> Pfizer have published a series of 2-Imidazole Alpha1A Adrenoceptor Partial Agonists

]]> http://gpcrcentral.wordpress.com/2008/10/24/pfizer-publish-series-of-alpha1a-adrenoceptor-partial-agonists/feed/ 0 crimsoncanary J&J publish series of CCR2 antagonists http://gpcrcentral.wordpress.com/2008/10/24/jj-publish-series-of-ccr2-antagonists/ http://gpcrcentral.wordpress.com/2008/10/24/jj-publish-series-of-ccr2-antagonists/#comments Fri, 24 Oct 2008 16:56:43 +0000 crimsoncanary http://gpcrcentral.wordpress.com/?p=425 ]]> J&J have published a series of 7-Azaindole Piperidine CCR2 Antagonists

]]> http://gpcrcentral.wordpress.com/2008/10/24/jj-publish-series-of-ccr2-antagonists/feed/ 0 crimsoncanary Daiichi Sankyo and Lilly continue talks with FDA re Prasugrel NDA http://gpcrcentral.wordpress.com/2008/10/24/daiichi-sankyo-and-lilly-continue-talks-with-fda-re-prasugrel-nda/ http://gpcrcentral.wordpress.com/2008/10/24/daiichi-sankyo-and-lilly-continue-talks-with-fda-re-prasugrel-nda/#comments Fri, 24 Oct 2008 16:55:21 +0000 crimsoncanary http://gpcrcentral.wordpress.com/?p=420 ]]> Daiichi Sankyo and Lilly are continuing to have discussions with the FDA regarding the review of the NDA for Prasugrel

]]> http://gpcrcentral.wordpress.com/2008/10/24/daiichi-sankyo-and-lilly-continue-talks-with-fda-re-prasugrel-nda/feed/ 0 crimsoncanary Glenmark/Lilly suspend trials with TRPV1 antagonist GRC 6211 in OA http://gpcrcentral.wordpress.com/2008/10/24/glenmarklilly-suspend-trials-with-trpv1-antagonist-grc-6211-in-oa/ http://gpcrcentral.wordpress.com/2008/10/24/glenmarklilly-suspend-trials-with-trpv1-antagonist-grc-6211-in-oa/#comments Fri, 24 Oct 2008 16:50:41 +0000 crimsoncanary http://gpcrcentral.wordpress.com/?p=418 ]]> Glenmark and Lilly have announced they have suspended further clinical development for TRPV1 antagonist GRC 6211 in Osteoarthritis pain.

]]> http://gpcrcentral.wordpress.com/2008/10/24/glenmarklilly-suspend-trials-with-trpv1-antagonist-grc-6211-in-oa/feed/ 0 crimsoncanary NeurogesX Submit NDA for NGX-4010 for Treatment of Postherpetic Neuralgia (PHN) http://gpcrcentral.wordpress.com/2008/10/24/neurogesx-submit-nda-for-ngx-4010-for-treatment-of-postherpetic-neuralgia-phn/ http://gpcrcentral.wordpress.com/2008/10/24/neurogesx-submit-nda-for-ngx-4010-for-treatment-of-postherpetic-neuralgia-phn/#comments Fri, 24 Oct 2008 16:46:56 +0000 crimsoncanary http://gpcrcentral.wordpress.com/?p=414 ]]> NeurogesX have submitted a new drug application (NDA) with the U.S. FDAS for NGX-4010 Dermal Capsaicin Patch for the management of pain due to postherpetic neuralgia (PHN).

]]> http://gpcrcentral.wordpress.com/2008/10/24/neurogesx-submit-nda-for-ngx-4010-for-treatment-of-postherpetic-neuralgia-phn/feed/ 0 crimsoncanary Progenics and Ono to Codevelop Relistor in Japan http://gpcrcentral.wordpress.com/2008/10/22/progenics-and-ono-to-codevelop-relistor-in-japan/ http://gpcrcentral.wordpress.com/2008/10/22/progenics-and-ono-to-codevelop-relistor-in-japan/#comments Wed, 22 Oct 2008 16:50:44 +0000 crimsoncanary http://gpcrcentral.wordpress.com/?p=422 ]]> Ono have signed an agreement to license Relistor (methylnaltrexone bromide) from Progenics for development in Japan

]]> http://gpcrcentral.wordpress.com/2008/10/22/progenics-and-ono-to-codevelop-relistor-in-japan/feed/ 0 crimsoncanary